REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Mara Plus, S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Research and Development in the Social Sciences and Humanities | Marketing Research and Public Opinion Polling
Full name: Mara Plus, S.R.O. Profile Updated: July 21, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Mara Plus, S.R.O. is an enterprise in Slovakia, with the main office in Bratislava. It operates in the Pharmacies and Drug Stores industry. The company was established on June 15, 2006. It currently has a total number of 3 - 4 (2025) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 15.87% in 2024. Over the same period, its total assets grew by 10.29%. The net profit margin of Mara Plus, S.R.O. increased by 2.35% in 2024.

Headquarters
Kapicova 1
Bratislava; Bratislavsky; Postal Code: 85101

Contact Details: Purchase the Mara Plus, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Mara Plus, S.R.O. report to view the information.
Registered Capital:
Purchase the Mara Plus, S.R.O. report to view the information.
Financial Auditors:
Purchase the Mara Plus, S.R.O. report to view the information.
Incorporation Date:
June 15, 2006
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Mara Plus, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
15.87%▲
Total operating revenue
15.47%▲
Operating profit (EBIT)
44.41%▲
EBITDA
35.77%▲
Net Profit (Loss) for the Period
78.4%▲
Total assets
10.29%▲
Total equity
9.19%▲
Operating Profit Margin (ROS)
1.67%▲
Net Profit Margin
2.35%▲
Return on Equity (ROE)
-45.24%▼
Quick Ratio
0.05%▲
Cash Ratio
0.14%▲

Similar companies

Dr.Max 100 S.R.O.
 
Lekaren Rpt, S. R. O.
Benu Sk 77, S. R. O.
 
Lekaren Arcus, S.R.O.
Unizdrav Presov, S.R.O.
 
Z&T Pharma S.R.O.
Lymapharm, S.R.O.
 
Benu Sk 100, S. R. O.
Dr.Max 80 S.R.O.
 
Lekaren Herbaria, S. R. O.
Pumed, S. R. O.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo